RhumbLine Advisers’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $1.2M | Buy |
|
|||||
|
2022
Q2 | $506K | Buy |
|
|||||
|
2022
Q1 | $451K | Buy |
|
|||||
|
2021
Q4 | $340K | Buy |
|
|||||
|
2021
Q3 | $546K | Buy |
|
|||||
|
2021
Q2 | $735K | Sell |
|
|||||
|
2021
Q1 | $825K | Sell |
|
|||||
|
2020
Q4 | $687K | Buy |
|
|||||
|
2020
Q3 | $583K | Sell |
|
|||||
|
2020
Q2 | $935K | Buy |
|
|||||
|
2020
Q1 | $807K | Sell |
|
|||||
|
2019
Q4 | $1.47M | Buy |
|
|||||
|
2019
Q3 | $1.12M | Buy |
|
|||||
|
2019
Q2 | $1.7M | Buy |
|
|||||
|
2019
Q1 | $2.24M | Sell |
|
|||||
|
2018
Q4 | $1.71M | Buy |
|
|||||
|
2018
Q3 | $1.99M | Sell |
|
|||||
|
2018
Q2 | $2.34M | Buy |
|
|||||
|
2018
Q1 | $1.73M | Sell |
|
|||||
|
2017
Q4 | $1.9M | Sell |
|
|||||
|
2017
Q3 | $1.78M | Buy |
|
|||||
|
2017
Q2 | $1.83M | Buy |
|
|||||
|
2017
Q1 | $1.53M | Buy |
|
|||||
|
2016
Q4 | $1.13M | Buy |
|
|||||
|
2016
Q3 | $907K | Buy |
|
|||||
|
2016
Q2 | $404K | Buy |
|
|||||
|
2016
Q1 | $255K | Buy |
|
|||||
|
2015
Q4 | $479K | Buy |
|
|||||
|
2015
Q3 | $310K | Buy |
|
|||||
|
2015
Q2 | $296K | Buy |
|
|||||
|
2015
Q1 | $292K | Buy |
|
|||||
|
2014
Q4 | $234K | Buy |
|